The v-rel oncogene is the most efficient transforming member of the Rel/NF-jB family of transcription factors. v-Rel induces avian and mammalian lymphoid cell tumors and transforms chicken embryo fibroblasts in culture by the aberrant regulation of genes under the control of Rel/ NF-jB proteins. Here we report that the expression of SH3BGRL, a member of the SH3BGR (SH3 domainbinding glutamic acid-rich) family of proteins, is downregulated in v-Rel-expressing fibroblasts, lymphoid cells, and splenic tumor cells. Chromatin immunoprecipitation experiments demonstrated that v-Rel binds to the sh3bgrl promoter in transformed cells. Coexpression of SH3BGRL with v-Rel in primary splenic lymphocytes reduced the number of colonies formed by 76%. Mutations in the predicted SH3-binding domain of SH3BGRL abolished the suppressive effect on v-Rel transformation and resulted in colony numbers comparable to those formed by v-Rel alone. However, mutations in the predicted EVH1-binding domain of SH3BGRL only had a modest effect on suppression of v-Rel transformation. This study provides the first example of a gene that is downregulated in v-Rel-expressing cells that also plays a role in v-Rel transformation.
Introduction
The Rel/NF-kB family of transcription factors plays an important role in mediating immune responses, developmental growth, inflammatory responses, and apoptosis in response to a wide variety of stress-inducing stimuli (Denk et al., 2000; Chen et al., 2001; Li and Verma, 2002; Bonizzi and Karin, 2004; Hayden and Ghosh, 2004) . The vertebrate Rel/NF-kB family consists of structurally related proteins that include NF-kB1 (p50/ p105), NF-kB2 (p52/p100), RelA (p65), c-Rel, and RelB (Gilmore, 1995) . All Rel/NF-kB family members share a highly conserved N-terminal Rel homology domain (RHD), which is responsible for DNA-binding and dimerization (Bose, 1992; Gilmore, 1995) . Rel/NF-kB proteins are maintained as homodimers or heterodimers in the cytoplasm of cells by the IkB family of inhibitory proteins (Cheng et al., 1994; Chiao et al., 1994) . Upon proper external stimuli, the N-terminal regulatory domains of IkBs are phosphorylated by the IkB kinase complex (Cheng et al., 1994; Chiao et al., 1994) . Phosphorylation targets the IkBs for ubiquitin-mediated proteasomal degradation, resulting in the release and nuclear translocation of NF-kB complexes (Kerr et al., 1991) . Once in the nucleus, the active Rel/NF-kB dimers can bind to 10 base pair DNA sequences (kB sites) and promote transcription of downstream genes such as ikba (Cheng et al., 1994) . The expression of IkBa is thus autoregulated to maintain a basal level of NF-kB activity in normal cells (Chiao et al., 1994) .
Disruptions in the regulation of Rel/NF-kB proteins have been implicated in a variety of cancers (Karin et al., 2002; Madrid and Baldwin, 2003) . The first evidence of the involvement of the Rel/NF-kB family in oncogenic cell transformation came from studies on the v-rel oncogene (Stephens et al., 1983) . The v-rel oncogene, originally isolated from the avian reticuloendotheliosis virus REV-T, is the most efficient transforming member of the Rel/NF-kB family. v-Rel is able to induce avian and mammalian lymphoid cell tumors and transforms chicken embryo fibroblasts (CEFs) in culture (Franklin et al., 1977; Moore and Bose, 1988; Bose, 1992; Carrasco et al., 1996) . v-Rel is evolutionarily derived from the avian proto-oncoprotein c-Rel and differs by two N-terminal amino-acid deletions, several point mutations, and a C-terminal truncation (Stephens et al., 1983; Wilhelmsen et al., 1984; Bull et al., 1990; Moore et al., 1993; Pahl, 1999) . v-Rel also has 11 N-terminal and 18 C-terminal env-derived sequences (Hrdlickova´et al., 1995a) . Unlike normal Rel/NF-kB proteins, v-Rel has evolved to evade the negative regulation of IkBa. The C-terminal truncation and alterations in the RHD have made v-Rel less susceptible to inhibition by IkBa and less efficient at activating transcription of ikba than c-Rel (Sarkar and Gilmore, 1993; Hrdlickova´et al., 1995b; Kralova et al., 1996; Sachdev and Hannink, 1998; Gilmore, 1999) . Escape from IkB regulation allows the constitutive nuclear localization of v-Rel homodimers and heterodimers with other members of the Rel/NF-kB family, where they bind to kB sites in the promoter of target genes normally regulated by Rel/NF-kB proteins (Kabrun et al., 1991; Baldwin, 1996) .
Although it is now well established that v-Rel transforms cells by affecting the transcription of Rel/NF-kB targets, relatively few examples of genes have been identified with altered expression in v-Reltransformed cells. Some examples of v-Rel upregulated genes include ikba, the transcription factors c-rel, nf-kb1, nf-kb2, c-jun, c-fos, IRF-4, and IRF-10, cytokines such as MIP-1b and IL-6, the cell surface molecules DM-GRASP and p75, and the antiapoptotic proteins ch-IAP1 and Nr13 (Zhang et al., 1995; Zhang and Humphries, 1996; Petrenko et al., 1997; Kralova et al., 1998 Kralova et al., , 2002 Lee et al., 1999; Hrdlickova´et al., 2001; Nehyba et al., 2002) . Of these, only AP-1 and IRF-4 have been directly implicated in v-Rel-mediated transformation (Kralova et al., 1998; Hrdlickova´et al., 2001) . A few genes exhibit decreased expression patterns in v-Rel-transformed cells. These include nap-1, eif-2a, c-myb, and the AP-1 transcription factor fra-2 (Petrenko et al., 1997; Kralova et al., 1998) . It is expected that the normal expression of these genes restricts or otherwise diminishes the transforming effect of v-Rel, but this remains to be demonstrated.
Here we report that the expression of SH3BGRL is downregulated in v-Rel-expressing cells. This protein belongs to the SH3 domain-binding glutamic acid-rich protein (SH3BGR) family of proteins, which also includes SH3BGR, SH3BGRL2, and SH3BGRL3, the first of which was mapped to the region of chromosome 21 responsible for congenital heart disease in down syndrome patients (Scartenzzini et al., 1997; Egeo et al., 1998; Mazzocco et al., 2001 Mazzocco et al., , 2002 . The protein sequences of all the members except SH3BGRL3 contain two overlapping predicted proline-rich proteinbinding domains, a Src homology 3-(SH3-) and an Ena/ Vasp Homology 1-(EVH1-) binding domain. Protein interactions involving SH3 domains have been implicated in signal transduction, cytoskeletal rearrangements, membrane trafficking, and other key cellular processes (Cesareni et al., 2002) . The EVH1-binding domain has not been characterized extensively; however, the corresponding EVH1 domain-containing proteins have been shown to be involved in neuronal excitatory processes and in regulating the actin cytoskeleton (Ball et al., 2002) . Since the normal biological functions of the SH3BGR family members have yet to be elucidated, the roles played by the putative SH3-and EVH1-binding domains in these proteins remain unclear.
In this study, we report the downregulation of SH3BGRL as an important step for v-Rel-mediated transformation. SH3BGRL transcripts were downregulated in response to v-Rel in fibroblasts, lymphoid cells, and splenic tumors. The promoter of sh3bgrl contains a kB site that can be bound by v-Rel complexes in nuclear extracts, and chromatin immunoprecipitation (ChIP) experiments revealed that v-Rel is bound to this promoter in a v-Rel-transformed cell line. Overexpression of SH3BGRL in primary splenic lymphocytes diminished the transforming properties of v-Rel. Moreover, mutations in the predicted SH3-binding domain in SH3BGRL abolished this effect and led to equal numbers of colonies formed as v-Rel alone. These experiments provide the first example of a downregulated gene in v-Rel-expressing cells that also plays a role in v-Rel transformation.
Results
Identification and characterization of a v-Rel downregulated gene and related family members Differential display was employed to identify genes with altered expression in v-Rel-transformed CEFs. Total RNA was harvested from CEFs expressing v-Rel after the cells became morphologically transformed. The profile of expressed genes from normal CEFs, CEFs transfected with an empty RCAS retroviral vector, or CEFs transfected with RCAS expressing v-rel was compared by differential display (Figure 1a ). Among the cDNAs identified was an 89 bp DNA fragment that was downregulated in v-Rel-transformed cells. The band was excised, amplified by PCR, cloned into a plasmid vector, and used as a probe in Northern blot analysis of total RNA from CEFs transfected with the empty RCAS vector or with RCAS expressing v-rel ( Figure 1b) . The radiolabeled cDNA probe hybridized with a 3.2 kb transcript that was expressed at lower levels in the v-Rel-transformed cells relative to control cells.
In order to obtain the full-length cDNA sequence, the 89 bp DNA fragment was used as a probe to screen a CEF cDNA library. The longest positive clone included (Figure 2a ). Sequence analysis of the gene revealed a 345-bp-long open reading frame (ORF) that predicts a 114 amino acid-long protein product.
Database searches using the protein sequence revealed this to be the chicken ortholog of SH3BGRL (SH3-binding-glutamic acid-rich protein like). Chicken SH3BGRL shares 86 and 85% identity with the human and mouse homologs, respectively (Figure 2b ).
SH3BGRL is a member of the SH3BGR family of proteins, which includes three additional members: 
- Suppression of SH3BGRL in v-Rel-mediated transformation SM Majid et al SH3BGR, SH3BGRL2, and SH3BGRL3. The BBSRC chickEST database was searched by BLAST analysis using the human and mouse protein sequences in order to identify the chicken orthologs of these family members ( Figure 2b ). The chicken SH3BGR protein is 157 amino acids long and shares 82% sequence identity with the mouse and human homologs. The published human SH3BGR sequence used in the homology studies is 64 amino acids longer at the N-terminus than the corresponding proteins from mouse and chicken. The chicken SH3BGRL2 protein is 97 amino acids long and is about 83% identical to its human and mouse homologs. The SH3BGRL3 protein is 93 amino acids long in all the three organisms examined. The chicken SH3BGRL3 protein shares 90 and 88% identity with the human and mouse proteins. As evident from the alignment, the SH3BGRL3 sequences are more divergent from the other members. All three SH3BGRL3 homologs have a different N-terminus and lack the conserved polyproline sequences that define potential SH3-or EVH1-binding domains in the other SH3BGR proteins.
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To investigate whether there is a difference in the expression patterns of the chicken sh3bgr family members, Northern blot analysis was performed using RNA isolated from tissues from 3-week-old chickens ( Figure 3 ). The sizes of the sh3bgrl, sh3bgr, sh3bgrl2, and sh3bgrl3 transcripts are about 3.4, 1.4, 6 kb, and between 1.3 and 0.8 kb, respectively. Similar to expression in human tissues, the endogenous expressions of sh3bgrl, sh3bgrl2, and sh3bgrl3 were detected in all chicken tissues examined, while the expression of sh3bgr was restricted to muscle tissues (Scartenzzini et al., 1997; Egeo et al., 1998; Mazzocco et al., 2001 Mazzocco et al., , 2002 . Both sh3bgrl and sh3bgrl3 were highly expressed in lymphoid tissues (spleen, bursa, and thymus), while exhibiting low levels of expression in the liver, skeletal muscle, and kidney. sh3bgrl2 was expressed highest in the brain and lung, and relatively low levels of expression were detected in the other tissues examined.
SH3BGR family members have different expression patterns in transformed cells
To determine whether family members other than SH3BGRL exhibit expression patterns suggestive of a role in v-Rel-mediated transformation, their expression patterns were analysed in cells following infection by viruses expressing v-Rel and c-Rel. Since v-Rel is more transforming than c-Rel, genes that are involved in the transformation process are likely to exhibit unique or more dramatic changes in expression in response to v-Rel, relative to c-Rel. Thus, CEFs and DT95 cells (a chicken B-cell line) were infected with retroviruses expressing c-Rel (REV-C) or v-Rel (REV-TW) or with the helper virus chicken syntitial virus (CSV), and RNA and protein were extracted 10-14 days post-infection when v-Rel-expressing cells were morphologically transformed. Since the adaptation of primary cell cultures and transformed cell lines to conditions in vitro may influence the expression patterns observed, the expression of sh3bgr family members was also investigated in tumors induced by v-Rel. Splenic tumors were induced in 1-day-old chicks by intraperitoneal injection with the v-Rel-expressing retrovirus REV-TW. Control birds were injected with the helper virus CSV. When the REV-TW-infected birds appeared moribund (7-10 days post-infection), protein and RNA were extracted from purified splenic lymphocytes from both groups of chickens. The spleens of v-Rel-infected chickens were approximately 50% larger than those of control birds and had visible tumors. The expression levels of the sh3bgr family members in v-Rel-expressing CEFs, DT95 cells, and splenic tumor cells were analysed by Northern blot analysis ( Figure 4a A good correlation was established between the expression of sh3bgrl RNA and protein levels in all the cells examined. In both CEFs and DT95 cells, v-Rel was more efficient at downregulating the expression of sh3bgrl than was c-Rel. The levels of sh3bgrl RNA and protein were upregulated about two-fold in c-Relexpressing CEFs, whereas they were downregulated three-fold in v-Rel-transformed CEFs, relative to control CSV-infected CEFs. In DT95 cells, sh3bgrl expression was downregulated to a greater extent by v-Rel (2.8-fold RNA and six-fold protein) than by c-Rel (2.2-fold RNA and about five-fold protein) relative to the CSV control. The expression of sh3bgrl was reduced about 2.5-fold in the v-Rel-induced splenic tumor cells at both the protein and RNA levels, compared to CSVinfected splenic cells.
In contrast to sh3bgrl, the changes in expression of sh3bgrl2 and sh3bgrl3 were not consistent in response to v-Rel across the three cell types. sh3bgrl2 expression, although low in all three cell types, was unchanged in CEFs, elevated in DT95 cells, and reduced in the v-Relinduced splenic tumors. Expression of sh3bgrl3 was elevated in CEFs expressing v-Rel, reduced in DT95 cells expressing v-Rel, and not significantly altered in the Figure 3 Expression of SH3BGR family members in chicken tissues. Northern blot analysis was performed using total RNA (10 mg) isolated from the indicated tissues from 3-week-old chickens to determine expression of sh3bgrl, sh3bgr, sh3bgrl2, and sh3bgrl3. Methylene blue-stained 18S rRNA is shown as the loading control.
Suppression of SH3BGRL in v-Rel-mediated transformation SM Majid et al splenic tumors. sh3bgr expression was undetectable in both CEFs and DT95 cells (data not shown).
To determine whether the decreased expression of SH3BGRL was specific to the v-Rel transformation pathway, the RNA and protein levels of SH3BGRL were analysed in a panel of cell lines composed of an immortalized CEF cell line and lymphoid cell lines transformed by v-Rel or other oncogenes (Figure 4c ). All of these cell lines expressed SH3BGRL, with MSB1 and BM2 expressing the highest amounts at both the RNA and protein levels. Relative to the other avian transformed cell lines, the expression of SH3BGRL was consistently lower in each of the v-Rel-transformed cell lines.
The promoter of SH3BGRL is bound by v-Rel in transformed cells Since the levels of sh3bgrl were consistently reduced in v-Rel-expressing cells, we examined whether this decreased expression may be a direct effect of v-Rel. v-Rel alters the expression of c-jun, ch-IAP1, and ikba by binding to kB sites in the promoters of these genes that reside in close proximity to their transcription start sites (Schatzle et al., 1995; Fujii et al., 1996; Kralova et al., 2002) . To determine whether v-Rel may also directly alter the expression of sh3bgrl, the genomic sequences upstream of sh3bgrl were compared with the TRANS-FAC database using the transcription factor element search system (TESS) (Petsko, 2002) . Two potential kB sites were identified 154 and 194 base pairs upstream of the transcription start site (Figure 5a ). To evaluate whether these encode genuine kB sites that can be bound by v-Rel, DNA probes containing these sequences were used in electrophoretic mobility shift assays (EMSAs) with nuclear extracts from the v-Rel-transformed cell line 160/2 (Figure 5b ). Supershift analyses using antisera specific for v-Rel demonstrated that three v-Rel-containing complexes were able to bind to the kB site found at À194. In contrast, no v-Rel-containing complexes bound to the predicted kB site found at À154.
To ascertain whether v-Rel is bound to the promoter of sh3bgrl in transformed cells, ChIP experiments were performed with antisera specific for v-Rel, normal rabbit IgG, or no antibody (Figure 5c ). DNA from these ChIPs was analysed by PCR with primers specific to the sh3bgrl promoter (À156 to À467). Consistent with the ability of v-Rel to bind to the kB site at À194, the sh3bgrl promoter was specifically amplified in ChIP assays performed with v-Rel-specific antisera, but not with normal rabbit IgG or those performed in the absence of antibody. Primers flanking a region of the alpha-2 type I collagen (COLA) gene that is devoid of kB sites served as a negative control for these experiments. Although these sequences were amplified by PCR using control input DNA, significant amplification of these sequences was not observed in the various ChIP samples.
Overexpression of SH3BGRL inhibits v-Rel transformation
The levels of sh3bgrl RNA and protein were consistently reduced in cells expressing v-Rel and in v-Rel-induced splenic tumors, relative to control cells (Figure 4 ). To determine if the reduced expression of sh3bgrl contributes to v-Rel-mediated transformation, SH3BGRL was overexpressed with v-Rel in spleen cell transformation assays. Viral constructs were made using a bicistronic spleen necrosis virus-based retroviral vector pBIS, which allowed for expression of up to two genes from a single virus (Figure 6a ). Viruses were constructed to individually express v-Rel from the splice acceptor site (BIS-V) or SH3BGRL from the internal ribosomal entry site (BIS-BGRL), or to coexpress both v-Rel and SH3BGRL (BIS-V þ BGRL). The overexpression of SH3BGRL and the expression of v-Rel by the appropriate viruses were confirmed by Western blot analysis (Figure 6b ). Primary splenic lymphocytes from 3-weekold chickens were infected with these viruses and plated in soft agar. Plates were scored for colony formation after 10 days. The results from three individual experiments demonstrated that approximately 75% fewer colonies were formed when SH3BGRL was coexpressed with v-Rel than when v-Rel was expressed alone (Table 1 ). This result indicates that the overexpression of SH3BGRL significantly (Pp0.03) inhibits the initiation of v-Rel transformation.
Since lower expression levels of SH3BGRL were observed in v-Rel-transformed cell lines compared to cell lines transformed by other oncogenes (Figure 5c ), the effect of SH3BGRL overexpression on the maintenance of v-Rel transformation was analysed. The sh3bgrl gene was cloned into the pTZDS-XB retroviral vector to produce viruses (DS-BGRL) capable of infecting the v-Rel-transformed cell lines. The DS viruses were used to infect (multiplicity of infection (MOI) ¼ 7) three different v-Rel-transformed lymphoid cell lines: 160/2 (a T-cell line), 123/12 (a B-cell line), and 123/6T (a non-B/non-T-cell line). Whole-cell lysates were prepared 5 days after infection and expression of v-Rel and overexpression of SH3BGRL was confirmed by Western blot analysis (Figure 7a ). Cells were plated in media containing soft agar 7 days after infection and scored for colony formation after a further 10-14 days (Figure 7b ). Colony counts revealed a 36% reduction (Pp0.03) in 160/2 cells, a 28% reduction (Pp0.01) in 123/12 cells, and a 31% reduction (Pp0.01) in 123/6T Suppression of SH3BGRL in v-Rel-mediated transformation SM Majid et al colony numbers due to DS-BGRL infection when compared to infection with the empty DS vector. This difference in colony formation is not due to an effect on the growth rate of the cells since cell counts during this period did not reveal significant differences in growth between infected and uninfected cells for each cell line (data not shown).
The SH3-binding domain is important for SH3BGRL to function as an inhibitor of v-Rel transformation SH3BGRL proteins from human, chicken, and mouse share a region of overlapping proline-rich domains that are strongly conserved (Figure 2b ). The proline-rich domains include a predicted class I SH3-binding domain that has a conserved core PXXP motif (amino acids 64-67; X is any amino acid) (Mayer, 2001) . A proline is also found at amino acid 59, which has been observed in certain SH3-binding domains (Tong et al., 2001) . A predicted class II EVH1 recognition domain has also been found that contains the conserved PPXXF sequence (amino acids 66-70; X is any amino acid) (Tu et al., 1998; Barzik et al., 2001 ). An aspartic acid at amino acid 72 is conserved in a subset of EVH1-binding domains (Barzik et al., 2001; Ball et al., 2002) . To determine whether the ability of SH3BGRL to inhibit v-Rel transformation requires intact SH3-and EVH1-binding domains, mutations were introduced into these conserved regions (Figure 8a ). Two mutants (SH3BGRLm1 and SH3BGRLm2) were specific for the SH3-binding domain (P59A and P64A), one mutant (SH3BGRLm3) contained two mutations in the EVH1-binding domain (F70A, D72A), and two mutants (SH3BGRLm4 and SH3BGRLm5) disrupted both SH3-and EVH1-binding domains (P67A and P64A, P67A). Similar mutations in other proteins have been demonstrated to disrupt interactions between SH3 and EVH1 domains and known binding partners (Grabs et al., 1997; Barzik et al., 2001) .
Viruses were generated using the pBIS bicistronic retroviral vector described above to enable expression of each SH3BGRL mutant protein alone or with v-Rel. The overexpression of SH3BGRL, SH3BGRL mutants, and the expression of v-Rel from these viruses were confirmed by Western blot analysis (Figure 8b) . Each of the SH3BGRL mutants was expressed at levels comparable to that of ectopically expressed wild-type SH3BGRL. Transformation assays were performed by infection of primary splenic lymphocytes from 3-weekold chickens. The cells were plated in soft agar after 3 days and plates were scored for colonies after a further 14-16 days (Figure 8c ). Coexpression of wild-type SH3BGRL with v-Rel reduced colony formation by 62% (Pp0.00001), relative to expression of v-Rel alone. Expression of SH3BGRLm1 or m2, which have amino acids mutated in the predicted SH3-binding domain, resulted in little or no change in colony numbers when expressed with v-Rel. The expression of SH3BGRLm3, which has mutations in the predicted EVH1-binding domain, reduced colony formation by v-Rel by 48% (Pp0.03), a level comparable to that observed with wild-type SH3BGRL. However, the ability of the EVH1-binding domain mutant of SH3BGRL to inhibit colony formation is significantly reduced (Pp0.001) relative to that of the wild-type protein. Expression of SH3BGRLm4 or m5, which have mutations overlapping both domains, resulted in colony numbers comparable to m1 or m2, but not m3. by the inappropriate activation or suppression of genes normally under the regulation of Rel/NF-kB proteins. The majority of target genes of v-Rel identified to date are upregulated in response to direct or indirect regulation by v-Rel. Evidence has been provided for the involvement of only a few of these genes in the transformation of cells by v-Rel. However, none of the v-Rel downregulated genes identified so far have been biologically implicated in v-Rel transformation. In this study, we identify a novel downregulated gene in v-Reltransformed cells, sh3bgrl, the suppression of which is important for v-Rel transformation.
SH3BGRL was identified in differential display experiments to be downregulated in v-Rel-transformed CEFs. Subsequently, we have shown that RNA and protein levels of SH3BGRL are decreased in v-Reltransformed CEFs, in DT95 cells expressing v-Rel, and in v-Rel-induced splenic tumor cells (Figures 1 and 4) . Since v-Rel binds to a kB site in the promoter of sh3bgrl and is associated with this promoter in transformed cells ( Figure 5 ), it is likely that v-Rel directly participates in its decreased expression. In contrast to SH3BGRL, most of the other SH3BGR family members did not exhibit patterns of expression that were consistent with a role in v-Rel-mediated transformation. The expression of sh3bgr was not detected in cell types transformed by v-Rel (Figures 3 and 4 ) and the expression of sh3bgrl2, while decreased in v-Rel-induced splenic tumors, was not significantly altered in CEFs or DT95 cells expressing v-Rel (Figure 4) .
Although the changes in sh3bgrl3 expression were not consistent, they were dramatic and in proportion to the oncogenic potential of the Rel proteins expressed in CEFs and DT95 cells. An increase in sh3bgrl3 expression was observed in CEFs expressing v-Rel, and to a lesser extent in CEFs overexpressing c-Rel. In contrast, the expression of v-Rel or c-Rel in DT95 cells resulted in a decrease in sh3bgrl3 levels. sh3bgrl3 is the only member of the sh3bgr family for which a potential biological role has been characterized (Berleth et al., 1999) . The initial identification of SH3BGRL3 overlapped with another study that characterized this protein as TNF inhibitory protein B1 (TIP-B1). SH3BGRL3 (TIP-B1) was shown to be upregulated in response to TNFa and was able to block TNF-induced apoptosis when added exogenously to human fibroblast cell lines (Berleth et al., 1999 (Berleth et al., , 2000 Henn et al., 2001) . Since these studies did not show that TIP-B1 was secreted by cells, or that exogenously added TIP-B1 was able to enter cells, further experiments are necessary to determine whether the inhibition of TNF-induced apoptosis is a normal biological function of SH3BGRL3. Interestingly, a separate study showed that induction of v-Rel in a tetracycline-regulated system blocked TNFinduced apoptosis of HeLa cells (Zong et al., 1997) . Thus, the upregulation of SH3BGRL3 (TIP-B1) observed in CEFs expressing v-Rel may play a role in this cell type. Future experiments will investigate the significance of the cell type-specific expression of sh3bgrl3 in v-Rel-mediated transformation. In addition, the strong homology between SH3BGRL3 and the other Human SH3BGRL2 and SH3BGRL3 proteins localized to both the nucleus and cytoplasm in COS-7 cells (Mazzocco et al., 2001 (Mazzocco et al., , 2002 . To analyse the subcellular distribution of chicken SH3BGRL, we expressed SH3BGRL containing a C-terminal FLAG-tag in CEFs. The localization of this protein was analysed by immunofluorescence and found to mimic that of the other family members (data not shown). This pattern was unaffected by v-Rel since SH3BGRL-FLAG was also observed in both the nucleus and the cytoplasm in v-Rel-transformed CEFs (data not shown). These results suggest that while v-Rel efficiently downregulates the expression of SH3BGRL, it does not alter the subcellular distribution of SH3BGRL.
Transformation assays performed in this study demonstrate that the downregulated expression of SH3BGRL plays a significant function in v-Rel transformation. Coexpression of SH3BGRL and v-Rel diminished the transforming ability of v-Rel by 76% in splenic lymphocytes (Table 1 ). This reduction is not the result of a change in target cell specificity since 70% of the cell lines established from colonies transformed by the coexpression of v-Rel with SH3BGRL were of T-cell origin (data not shown). These findings are consistent with previous reports describing the target cell specificity of v-Rel (Barth et al., 1990) . Therefore, these combined results indicate that the initiation of transformation by v-Rel was inhibited by SH3BGRL in 76% of the cells infected.
In addition to its ability to initiate cell transformation, the continued expression of v-Rel is also required to maintain the transformed phenotype (White et al., 1995) . The v-Rel-regulated genes required for the initiation of transformation may or may not be required for the maintenance step. To assay its participation in maintenance of v-Rel transformation, the effect of SH3BGRL overexpression on the colony-forming ability of v-Rel-transformed cell lines was analysed. Overexpression of SH3BGRL resulted in an average reduction in colony numbers of 32% for each cell line tested (Figure 7) . Thus, it appears likely that the pathways impacted by SH3BGRL play a greater role in initiating v-Rel transformation rather than in maintaining the transformed phenotype. Since the exact biological function(s) of SH3BGRL is unknown, it remains to be seen whether SH3BGRL is a positive regulator of a pathway that inhibits v-Rel transformation or a negative regulator of one that promotes v-Rel transformation.
Based on the homology between SH3BGRL and other family members, we analysed the requirement of protein interaction domains of SH3BGRL for initiation of v-Rel transformation. A proline-rich region PASGNPLPPRLFND (amino acids 59-72) containing two potential protein interaction domains was identified in SH3BGRL (Egeo et al., 1998) . Mutations were made in either the SH3-(PASGNPLPP) or the EVH1-(PPRLFND) binding domains. Mutations in Pro59, which is conserved among all the SH3BGR members, and Pro64 disrupted the predicted SH3-binding domain. Mutations in Phe70 and Asp72 disrupted the EVH1-binding domain. Splenic lymphocytes coexpressing v-Rel and SH3BGRL mutants with disrupted SH3-binding domains formed colonies equal to or greater in number than v-Rel alone. Thus, the SH3-binding domain appears to be critical for SH3BGRL to function as an inhibitor of v-Rel transformation. The mutant with the disrupted EVH1-binding domain, however, maintained most of wild-type SH3BGRL function by inhibiting v-Rel transformation by 48%. Since expression of this mutant form did not completely inhibit colony formation to the extent of wild-type SH3BGRL, it is possible that interactions between SH3BGRL and an EVH1 domain-containing protein play an additional minor role in the ability of SH3BGRL to inhibit v-Rel transformation. However, it is also possible that the F70A and D72A mutations caused weakened interactions between the neighboring SH3-binding domain and interacting SH3 domain-containing proteins.
The characterization of genes regulated by v-Rel in transformation is critical to understanding the mechanisms by which v-Rel efficiently transforms cells. The deregulated expression of some v-Rel target genes (AP-1, IRF-4, and IAP1) has been implicated in human malignancies. Microarray analysis has revealed that SH3BGRL expression is downregulated in androgenindependent human cell lines derived from prostate tumors (Shi et al., 2004) . Interestingly, the activation of Rel/NF-kB temporally correlates with the progression of prostate tumor cells to androgen independence, at which point they become refractory to anticancer therapies (Thalmann et al., 2000; Gasparian et al., 2002; Suh et al., 2002; Suh and Rabson, 2004; Zhou et al., 2004) . Furthermore, recent studies have demonstrated that in human breast tumor cell lines, the expression of SH3BGRL is also suppressed relative to normal mammary epithelial cells (Mecham et al., 2004) . The role of elevated c-Rel expression and activity has been documented in the development of breast cancer (Sovak et al., 1997; Cogswell et al., 2000; Cao and Karin, 2003; Romieu-Mourez et al., 2003) . Although the suppression of SH3BGRL may be a common event in the development of cancers induced by aberrant Rel/ NF-kB activity, the inappropriate activation of Rel/NFkB proteins is not always sufficient to cause a reduction in the levels of sh3bgrl. While v-Rel suppressed sh3bgrl expression in all cell types examined, the overexpression of the less oncogenic c-Rel had differential effects on sh3bgrl levels in lymphocytes and fibroblasts (Figure 4) . It is likely that the ability of a specific Rel/NF-kB complex to suppress sh3bgrl expression enhances its ability to transform a particular cell type.
Materials and methods
General cell culture techniques
CEFs were prepared from 10-11-day-old embryos (Charles River SPAFAS, Wilmington, MA, USA) and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% chicken serum (Invitrogen Life Technologies, Carlsbad, CA, USA), 5% fetal bovine serum (Atlanta Biologicals, Atlanta, GA, USA), and 1% Antibiotic-Antimycotic (Invitrogen Life Technologies) in 8% CO 2 at 371C. Transformed chicken cell lines used in this study were maintained under the same conditions described above and included an immortalized CEF cell line (DF-1), two B-cell lines transformed by avian leukosis virus (DT40 and DT95), two T-cell lines transformed by Marek's disease virus (MSB1 and RP1), a macrophage-like cell line transformed by avian myeloblastosis virus (BM2), and a chicken erythroid cell line transformed by avian erythroblastosis virus (AEV) (Akiyama and Kato, 1974; Moscovici et al., 1982; Baba et al., 1985; Rao et al., 1990) . The v-Rel-transformed cell lines included a B-cell line (123/12), a T-cell line (160/2), and a non-B/non-T-cell line (123/6T) (Hrdlickova´et al., 1994) .
For induction of splenic tumors in vivo, 1-day-old chickens were injected intraperitoneally with the CSV or the reticuloendotheliosis virus (REV)-based retrovirus expressing v-Rel (REV-TW). Spleens were extracted from both groups of chickens 7-10 days after injection or at the first sign of illness in each REV-TW-infected bird. Cell suspensions were prepared by macerating the spleens through a nylon screen, and lymphocytes were isolated by differential gradient centrifugation using Histopaque-1077 (Sigma-Aldrich, St Louis, MO, USA).
Cloning of sh3bgrl and site-directed mutagenesis Differential display and cloning of a full-length sh3bgrl cDNA were performed using techniques previously described (You and Bose, 1998) . Briefly, 10 mg of total RNA was purified using the RNeasy kit (QIAGEN, Valencia, CA, USA) from normal CEFs, CEFs transfected with empty Rous sarcoma virusderived vector (RCAS), or CEFs transformed by RCASexpressing v-Rel. RNA differential display was carried out according to the RNAimaget kit (GenHunter, Nashville, TN, USA). The 89 bp fragment identified by differential display was cloned and used to screen a chicken CEF cDNA library. cDNAs that contained poly(A) tails were extended by RACE using oligonucleotides designed identical to the sequence 105 bp downstream of the 5 0 end of the longest isolated cDNA (5 0 -TAACTACAGCAAGGACTAATTACC-3 0 ) or identical to the 5 0 end (5 0 -GTGCCCTGAAGGATAAGAAACAGG-3 0 ) to obtain a cDNA encoding the full-length ORF.
Point mutations were made in the sh3bgrl ORF using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) using the following primers and their complementary sequences:
0 , and P64A/P67Amut 5 0 -CGG CCAGCCAGCGGGAACgCGCTGCCAgCCCGGCTCTT-3 0 . Mutations (lower case letters) were confirmed by sequencing (DNA Core Facility, The University of Texas at Austin, Austin, TX, USA).
Northern blot analysis Cells grown in culture and tissues isolated from chickens were harvested for RNA using RNAwiz (Ambion, Austin, TX, USA) according to the manufacturer's instructions. Each sample was normalized to a final concentration of 1 mg/ml in RNase-free water. Samples were diluted 1:2 in 2 Â loading buffer (2 Â MOPS (4.62% w/v MOPS (Sigma-Aldrich), 1.1% w/v sodium acetate trihydrate, and 0.42% w/v EDTA, pH 7.0), 4.7% glycerol, 0.05% bromophenol blue, 53.5% deionized formamide and 7.9% formaldehyde), denatured at 651C for 20 min, then loaded on a 1.0% agarose gel containing 2.1% formaldehyde for electrophoretic separation at 120 V for 2 h. RNA was transferred overnight onto a Hybondt-N þ nylon membrane (Amersham Biosciences, Piscataway, NJ, USA). The membrane was dried and RNA was crosslinked with UV at 1.2 Â 10 5 mJ/cm 2 using the FB-UVXL-1000 UV Crosslinker (Fisher Scientific, Hampton, NH, USA). Ribosomal RNA was visualized by staining the membrane with 0.02% Methylene blue in 0.3 M sodium acetate.
Northern blot analysis was carried out by hybridizing the membrane with 32 P-labeled probes specific for sh3bgr, sh3bgrl, sh3bgrl2, sh3bgrl3, or 18S rRNA using ULTRAhyb (Ambion) hybridization buffer according to the manufacturer's instructions. Chicken ESTs encoding the complete ORFs of sh3bgr (ChEST862I9), sh3bgrl2 (ChEST971A7), and sh3bgrl3 (ChEST894H8) were obtained from the BBSRC ChickEST Database (Swindon, UK) for generating the DNA probes. The 345-bp-long DNA sequence encoding the sh3bgrl ORF was used as the probe to detect sh3bgrl expression. The cDNA probes were labeled with [a-32 P]dATP using the StripEZ DNA kit (Ambion). A 20-mer oligonucleotide (5 0 -CGGAACTAC GACGGTATCTG-3 0 ) specific for the chicken 18S rRNA was end-labeled with [g-32 P]ATP to be used as a loading control for Northern blot analysis utilizing RNA from splenic tumors (Deindl, 2001) .
Western blot analysis
Proteins from cell extracts were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). For the analysis of SH3BGRL, proteins were resolved on 14% tricine gels (Schagger and Jagow, 1987) . The expression of c-Rel and v-Rel was detected by resolving proteins on 10% glycine gels (Sambrook et al., 1989) . Proteins were electrophoretically transferred to nitrocellulose membranes. SH3BGRL was detected by using a rabbit polyclonal antiserum raised against a GST fusion protein expressing the complete ORF of SH3BGRL. A peroxidase-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) was used as the secondary antibody. For detection of v-Rel and c-Rel, a 1:2 dilution of hybridoma supernatant fluids containing the mouse monoclonal antibody HY87 was employed (Schwartz and Witte, 1988) . The secondary antibody used was a peroxidaseconjugated F(Ab 0 ) 2 fragment donkey anti-mouse IgG (Jackson ImmunoResearch Laboratories).
Electrophoretic mobility shift assays Nuclear extracts were prepared from 160/2 cells using a modified NP-40 lysis protocol (Dyer and Herzog, 1995) . EMSA reactions were performed using 3 or 6 mg of protein in binding reactions consisting of 25 mM Tris pH 7.5, 75 mM NaCl, 1.5 mM EDTA, 7.5% glycerol, 0.3% NP-40, 1.5 mM DTT, 1 mg poly [dI Á dC], and 1.2 mg BSA. For supershift analyses, 5 mg of normal rabbit serum or antiserum specific for v-Rel (anti-R5) was added to the reactions and incubated on ice for 45 min (Kralova et al., 2002) . Labeled oligonucleotide probe (50 000 cpm) was added to the reactions and incubated at room temperature for 20 min. EMSA reactions were electrophoretically separated on a 5% acrylamide gel as described previously (Liss and Bose, 2002) .
The top strands of the oligodeoxynucleotides used as probes for EMSAs were as follows: kB-154 (5 0 -GTTCGTCGA GAATTCGCCTCACCCCTTTCTTTC-3 0 ) and kB-194 (5 0 -GCAGCGGGCAGCCCCCTCCTCCGAGCACGTC-3 0 ). The underlined sequences indicate the location of the predicted kB sites. The bottom strands of the probe were synthesized by annealing a 9-bp oligonucleotide complementary to the 3 0 end of the top strand and extending with Klenow in the presence of [ 32 P] dCTP (Hrdlickova´et al., 1995a) .
Chromatin immunoprecipitations
ChIP experiments were performed as described by Upstate Biotechnology (Chrlottesville, VA, USA), with some modifications. 160/2 cells (3 Â 10 7 ) were fixed in 1% formaldehyde for 10 min at 371C. Glycine was added to a final concentration of 0.125 mM and cells were incubated for 10 min at 371C to stop the crosslinking. Fixed cells were washed in PBS and nuclei isolated (Dyer and Herzog, 1995) . Nuclei were lysed in 300 ml SDS lysis buffer (1% SDS, 10 mM EDTA, and 50 mM Tris, pH 8.0) and sonicated for 15 s three times. A volume of lysate equivalent to 1 Â 10 6 cells was diluted to 200 ml and precleared for 1 h by incubation with 50 ml of protein-G agarose (50% slurry) that had been blocked with salmon sperm DNA and BSA. Cleared lysates were incubated for 1 h with 2 mg of normal rabbit IgG (Upstate Biotechnology) or with IgGpurified antibody specific for amino acids 488-503 of v-Rel (Hrdlickova´et al., 1995a) .
DNA recovered from the ChIPs was used in PCR with primers specific for sequences between À156 and À467 of the sh3bgrl promoter (sense primer: 5 0 -TGCCTCACACA CGCTGTATTTCAC-3 0 and antisense primer: 5 0 -ACGAAC CACGCGAGACGTGC-3 0 ), or that amplify a 100 base pair region of exon 6 of the alpha-2 type I collagen (COLA) gene (accession number: M25961) (sense primer: 5 0 -AAAGGGT CATGTGTACTGAG-3 0 and antisense primer: 5 0 -AGAAAG CACTGATAACCCTC-3 0 ). PCR was performed using 20 ng of input DNA or 10% of the recovered DNA from each ChIP and products resolved by agarose (sh3bgrl) or polyacrylamide (COLA) gel electrophoresis.
Construction of retroviral vectors
The pBIS bicistronic vector was derived from the spleen necrosis virus-based retroviral vector pJD216NeoHy (Dougherty and Temin, 1986) . This vector contains two LTRs flanking a neomycin resistance gene, a REV-A SA site, and a hygromycin resistance gene. A 0.6 kB SalI-NcoI fragment containing the internal ribosome entry site (IRES) from the encephalomyocarditis virus was isolated from pCITE-1 (Novagen, Madison, WI, USA) and cloned at the 3 0 end of the hygromycin resistance gene. A 0.7 kB NcoI-NotI fragment encoding EGFP was isolated from pEGFP-1 (Clontech, Palo Alto, CA, USA) and cloned at the 3 0 end of the IRES to create pJZ466 (kindly provided by Jiayou Zhang). The pBIS vector was constructed by replacing the hygromycin-resistance cassette with a multiple cloning site (MCS) that included XhoI and BssHII recognition sequences. The ORF encoding v-Rel was cloned into these sites to form the pBIS-V vector. The pIRES adapter vector was created by cloning a SalI-NotI fragment that contained the IRES and green fluorescent protein (GFP) from pBIS into pBluescript SK that had been digested with SalI and NotI. The sequences encoding GFP were excised by digestion with NcoI and NotI and replaced with a polylinker containing restriction sites for NcoI, XbaI, EcoRV, and NotI. The wild-type or mutant sh3bgrl genes were cloned into the NcoI and XbaI sites in the pIRES adapter vector. These genes were excised out together with the upstream IRES sequence by digestions with SalI and NotI. Each excised fragment was then cloned into SalI/NotIdigested pBIS and pBIS-V vectors for making BIS-based retroviruses.
DS-based retroviruses were constructed by cloning the sh3bgrl gene into the pTZDS-XB vector (containing the 3 0 portion of env and one LTR) within the XhoI/BssHII sites (Hrdlickova´et al., 2001) . This construct was then linearized by digestion with SalI and ligated to the SalI-digested pSR-REP-A vector (containing one LTR, gag, pol, and the 5 0 portion of env). The ligation reaction was then directly used for transfection of CEF cultures.
Preparation of retroviral stocks
All retroviral stocks were prepared by transfecting CEFs with the appropriate viral DNA as described before (Chen and Okayama, 1987) . CEFs were plated in 60 mm tissue culture dishes at 6 Â 10 5 cells/ml in serum-containing media and equilibrated at 361C and 3% CO 2 at least 30 min prior to transfection. Viral DNA (10 mg) together with the pCSV11S3 plasmid (0.3 mg, encoding the CSV helper virus) was mixed with 200 ml of 0.25 M CaCl 2 , to which an equal volume of N,Nbis[2-hydroxyethyl]-2-aminoethanesulfonic acid (BES)-buffered saline solution (50 mM BES, 280 mM NaCl, and 1.5 mM Na 2 HPO 4 ) was added. After 2 min, the DNA mixture was added to the cells, which were then incubated at 361C and 3% CO 2 overnight. For BIS-based retrovirus production, CEFs were treated with 0.5 mg/ml G418 (Fisher Scientific) after the second passage and virus was harvested 10 days later. DSbased viruses were harvested 6-7 days post-transfection. All viral stocks were aliquoted and stored at À801C.
The viral harvests were titered by dot-blot hybridization analysis using Hybondt-N þ nylon membrane (Amersham Biosciences) (Nelson et al., 1998) . Stocks of viruses with titers determined by immunohistochemical assays were employed as controls. Viral stocks (180 ml) were added to the membrane using a dot-blot transfer unit. Membranes were washed twice with 10 Â SSC, dried, and viral RNA crosslinked with UV at 1.2 Â 10 5 mJ/CM 2 using the FB-UVXL-1000 UV Crosslinker (Fisher Scientific). The membranes were hybridized with the appropriate probe in ULTRAhyb (Ambion) hybridization buffer according to manufacturer's instructions. For titration of BIS-based retroviruses, a neomycin resistance gene-specific probe was generated and randomly labeled with [a-32 P]dCTP (Prime-A-Gene Labeling System, Promega Corporation, Madison, WI, USA). For titration of the DS-based retroviruses, an 875-nucleotide long fragment was generated by digesting the pTZDS-XB vector with the SmaI and XhoI restriction enzymes. This fragment, which includes the ORF encoding the envelope protein of the virus, was randomly labeled with [a- 32 P]dCTP (Prime-A-Gene Labelling System, Promega). The hybridized probe was detected the next day and levels were normalized to the known titers of the control viruses by using ImageQuant 1.0.
In vitro transformation assays
In vitro transformation assays were performed using splenic lymphocytes isolated from 3-week-old chickens. Spleens were macerated through a nylon screen, and lymphocytes were isolated by differential gradient centrifugation with Histopaque-1077 (Sigma-Aldrich, St Louis, MO, USA). Purified lymphocytes were resuspended at a density of 2 Â 10 8 cells/ml and infected with viruses having a minimum titer of 1 Â 10 5 infectious units/ml. All viruses were diluted to the same titer in a final volume of 5 ml before the addition of 250 ml of the cell suspension. Cells infected with BIS-based retroviruses were resuspended in fresh media (15% fetal bovine serum and 5% chicken serum) 24 h after infection. After an additional 48 h, the cells were pelleted by centrifugation and resuspended in 12 ml of plating media prewarmed at 421C. The plating media consisted of DMEM containing 15% fetal bovine serum, 5% chicken serum, 1% Antibiotic-Antimycotic (Invitrogen Life Technologies), and 0.35% Noble agar (Becton Dickinson, Sparks, MD, USA). The cell suspension was divided equally into three 60 mm tissue culture plates, allowed to solidify, and then incubated at 371C and 8% CO 2 . Plates from each group of infections were scored microscopically for colony formation after 10-16 days.
Colony formation assays of v-Rel-transformed cell lines v-Rel-transformed cell lines were infected with empty DS retroviruses or DS retroviruses expressing SH3BGRL at a MOI of 6-10. Cells were maintained in complete medium and routinely split every two days. Uninfected cells from each cell line were grown in parallel. Ectopic expression of SH3BGRL was measured by Western blot analysis 5 days post-infection.
After 7 days, cell viability was determined by trypan blue exclusion. The 123/12 and 160/2 cells were plated in 0.35% soft agar at a concentration of 10 4 cells/plate, while the slowergrowing 123/6T cells were plated at 2 Â 10 4 cells/plate. The soft agar plating media consisted of DMEM containing 5% fetal bovine serum, 5% chicken serum, 1% Antibiotic-Antimycotic (Invitrogen Life Technologies), and 0.35% Noble agar (Becton Dickinson). The plates were incubated for 10-14 days before colonies were counted.
